MCID: DRM009
MIFTS: 37

Dermatomycosis

Categories: Infectious diseases, Skin diseases

Aliases & Classifications for Dermatomycosis

MalaCards integrated aliases for Dermatomycosis:

Name: Dermatomycosis 12 15
Dermatomycoses 44 73

Classifications:



External Ids:

Disease Ontology 12 DOID:1563
ICD9CM 35 111 111.9
MeSH 44 D003881
UMLS 73 C0011630

Summaries for Dermatomycosis

Disease Ontology : 12 A cutaneous mycosis that results in fungal infection located in skin or of its appendages, has material basis in Ascomycota fungi other than the dermatophytes.

MalaCards based summary : Dermatomycosis, also known as dermatomycoses, is related to eumycotic mycetoma and cutaneous mycosis. An important gene associated with Dermatomycosis is RPS3 (Ribosomal Protein S3). The drugs Amorolfine and Ciclopirox have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and lung, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 76 A dermatomycosis is a skin disease caused by a fungus. This excludes... more...

Related Diseases for Dermatomycosis

Graphical network of the top 20 diseases related to Dermatomycosis:



Diseases related to Dermatomycosis

Symptoms & Phenotypes for Dermatomycosis

GenomeRNAi Phenotypes related to Dermatomycosis according to GeneCards Suite gene sharing:

26 (show all 11)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-105 9.4 RPS3
2 Increased shRNA abundance (Z-score > 2) GR00366-A-115 9.4 ZBTB22
3 Increased shRNA abundance (Z-score > 2) GR00366-A-123 9.4 ZBTB22
4 Increased shRNA abundance (Z-score > 2) GR00366-A-126 9.4 RPS3
5 Increased shRNA abundance (Z-score > 2) GR00366-A-137 9.4 RPS3
6 Increased shRNA abundance (Z-score > 2) GR00366-A-178 9.4 RPS3
7 Increased shRNA abundance (Z-score > 2) GR00366-A-196 9.4 RPS3
8 Increased shRNA abundance (Z-score > 2) GR00366-A-208 9.4 ZBTB22 RPS3
9 Increased shRNA abundance (Z-score > 2) GR00366-A-36 9.4 ZBTB22
10 Increased shRNA abundance (Z-score > 2) GR00366-A-67 9.4 ZBTB22
11 Increased shRNA abundance (Z-score > 2) GR00366-A-78 9.4 ZBTB22

Drugs & Therapeutics for Dermatomycosis

Drugs for Dermatomycosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 156)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amorolfine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 78613-35-1
2
Ciclopirox Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 29342-05-0 2749
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
4
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
5
Voriconazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 137234-62-9 71616
6
Amphotericin B Approved, Investigational Phase 4,Phase 3,Phase 2 1397-89-3 14956 5280965
7
Caspofungin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 179463-17-3, 162808-62-0 468682 2826718
8
Ketoconazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 65277-42-1 47576 3823
9
Bifonazole Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 60628-96-8 2378
10
Terbinafine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 91161-71-6 5402 1549008
11
Naftifine Approved Phase 4,Phase 3,Phase 2,Phase 1 65472-88-0 73342 47641
12
Tavaborole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 174671-46-6
13
Itraconazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 84625-61-6 55283
14
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
15
Anidulafungin Approved, Investigational Phase 4,Phase 3,Phase 2 166663-25-8 166548
16
deoxycholic acid Approved Phase 4,Phase 3,Phase 2 83-44-3 222528
17
Posaconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 171228-49-2 147912
18
Micafungin Approved, Investigational Phase 4,Phase 3,Phase 2 235114-32-6 3081921 477468
19
Efinaconazole Approved Phase 4,Phase 3,Not Applicable 164650-44-6
20
Omalizumab Approved, Investigational Phase 4 242138-07-4
21 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
22 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
23 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
24 Cytochrome P-450 CYP3A Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
25 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
26 Dermatologic Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
27 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
28 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
29 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
30 Keratolytic Agents Phase 4,Not Applicable
31 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
32 Steroid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
33 Antacids Phase 4,Phase 1
34 Anti-Ulcer Agents Phase 4,Phase 1
35 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1
36 Proton Pump Inhibitors Phase 4,Phase 1
37 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Not Applicable
38 Antiparasitic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
39 Antiprotozoal Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
40 Liposomal amphotericin B Phase 4,Phase 3,Phase 2
41 Echinocandins Phase 4,Phase 3,Phase 2,Phase 1
42
Hydroxyitraconazole Phase 4,Phase 2,Phase 3,Phase 1
43 Antitussive Agents Phase 4
44 Chlorpheniramine, phenylpropanolamine drug combination Phase 4
45 Amphotericin B, deoxycholate drug combination Phase 4,Phase 3,Phase 2
46 Anti-Allergic Agents Phase 4,Phase 2,Phase 3
47 Anti-Asthmatic Agents Phase 4,Phase 2,Phase 3
48 Antibodies Phase 4,Phase 1
49 Immunoglobulin E Phase 4
50 Immunoglobulins Phase 4,Phase 1

Interventional clinical trials:

(show top 50) (show all 328)
# Name Status NCT ID Phase Drugs
1 Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis Unknown status NCT01014637 Phase 4 Amorolfine (Antifungal);RV4104A, Ciclopiroxolamine, Cyclopirox (Keratolytic Agents/Antifungal)
2 Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris Unknown status NCT02394340 Phase 4 Omeprazole 40mg
3 Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis Unknown status NCT02436291 Phase 4
4 Voriconazole for IPA in Chinese Patients With COPD Unknown status NCT02234739 Phase 4 Voriconazole
5 Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation Unknown status NCT00986713 Phase 4 Amphotericin B
6 Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease Unknown status NCT01499433 Phase 4 caspofungin
7 Safety and Efficacy of Product 33525 in Pediatric Subjects With Tinea Corporis Completed NCT02767947 Phase 4 Luliconazole Cream 1%;Vehicle Cream
8 An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis Completed NCT02466867 Phase 4 Naftin® Cream, 2% (younger pediatric cohort);Naftin® Cream, 2% (older pediatric cohort)
9 Pediatric Subjects With Tinea Corporis Completed NCT02227290 Phase 4 Naftin Cream;Placebo Cream
10 Ketoconazole Foam 2% for the Treatment of Versicolor Completed NCT00830388 Phase 4 Ketoconazole 2% Foam
11 A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections Completed NCT00647907 Phase 4 Voriconazole
12 COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis Completed NCT00334412 Phase 4 Ambisome;caspofungin
13 Maximal Use of Luliconazole Cream 1% in Pediatric Patients With Moderate to Severe Tinea Pedis or Tinea Cruris Completed NCT02767271 Phase 4 Luliconazole Cream 1%
14 An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents Completed NCT03405818 Phase 4 Tavaborole 5% Topical Solution
15 Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis Completed NCT01712360 Phase 4 NAFT500 (pediatric);NAFT600 (pediatric);NAFT500 (adult);NAFT600 (adult)
16 Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1% Completed NCT02705664 Phase 4 Loceryl Nail Lacquer;Urea Ointment;Bifonazole Cream
17 Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer Completed NCT02679911 Phase 4 Loceryl Nail Lacquer;Ciclopirox Nail Lacquer
18 A Pilot Study - Safety and Efficacy of Nailprotex® for Onychomycosis Treatment Completed NCT02464826 Phase 4 Nailprotex
19 Antifungal Activity of Loceryl Nail Lacquer in Combination With a Cosmetic Varnish Completed NCT02321098 Phase 4 Loceryl Nail Lacquer;Loceryl Nail Lacquer;Loceryl Nail Lacquer follow up period
20 Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis Completed NCT01851590 Phase 4 Amorolfine;Terbinafine
21 Topical Penlac Nail Lacquer for Onychomycosis in Children Completed NCT01419847 Phase 4 Ciclopirox;Placebo
22 Scoring Clinical Index For Onychomycosis in Toenail Onychomycosis Treating With Itraconazole Capsules Completed NCT00871728 Phase 4 Itraconazole
23 Efficacy Of Itraconazole In Chronic Cavitary Pulmonary Aspergillosis Completed NCT01259336 Phase 4 Itraconazole;treatment in cavitary pulmonary aspergillosis
24 A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects Completed NCT00940017 Phase 4 anidulafungin and voriconazole
25 Amphotericin-B and Voriconazole for Pulmonary Blastomycosis Recruiting NCT02283905 Phase 4 amphotericin-B;voriconazole
26 Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis Recruiting NCT03280927 Phase 4 Jublia®
27 Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte Onychomycosis Recruiting NCT02812043 Phase 4 Amorolfine
28 Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients Recruiting NCT03378479 Phase 4 SOC +Posaconazole 18 MG/ML (milligram/milliliter)
29 Study Evaluating the Effect of Jublia on Dermatophytomas Active, not recruiting NCT03098615 Phase 4 Jublia (Efinaconazole 10% Topical Solution)
30 Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish Active, not recruiting NCT03110029 Phase 4 Efinaconazole 10% (Jublia)
31 Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis Active, not recruiting NCT02812771 Phase 4 Efinaconazole
32 Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children Terminated NCT01646580 Phase 4 ciclopirox
33 Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp Terminated NCT02646800 Phase 4 Micafungin
34 Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis Terminated NCT02646774 Phase 4 Micafungin
35 Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene) Terminated NCT00620074 Phase 4 voriconazole;anidulafungin
36 An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA) Terminated NCT00787917 Phase 4 Omalizumab;Placebo;Itraconazole
37 A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis Withdrawn NCT00423163 Phase 4 micafungin;voriconazole
38 Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females Unknown status NCT00856596 Phase 3 Sertaconazole nitrate cream 2%
39 Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis Unknown status NCT01125644 Phase 3 SPK-843
40 Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections Unknown status NCT01105013 Phase 3 Clotrimazole
41 TDT 067 Onychomycosis Study Unknown status NCT01145807 Phase 3 TDT067;Placebo;Transfersome
42 Treating Onychomychosis Unknown status NCT00776464 Phase 2, Phase 3
43 Terbinafine Compared to Griseofulvin in Children With Tinea Capitis Completed NCT00117767 Phase 3 Terbinafine hydrochloride (HCl);Griseofulvin
44 Terbinafine Compared to Griseofulvin in Children With Tinea Capitis Completed NCT00117754 Phase 3 Terbinafine hydrochloride
45 Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris Completed NCT01885156 Phase 3 Naftin 1% Cream;Placebo Cream
46 Topical Antifungal Treatment for Tinea Cruris Completed NCT01342315 Phase 3 33525;Placebo
47 Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101) Completed NCT02180165 Phase 3 Posaconazole;Voriconazole
48 Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris Completed NCT00750152 Phase 3 NAFT-500;Placebo
49 A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED) Completed NCT00717860 Phase 3 caspofungin acetate;Comparator: Micafungin sodium
50 Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi Completed NCT00634049 Phase 3 isavuconazole

Search NIH Clinical Center for Dermatomycosis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: dermatomycoses

Genetic Tests for Dermatomycosis

Anatomical Context for Dermatomycosis

MalaCards organs/tissues related to Dermatomycosis:

41
Skin, Testes, Lung, Bone, Myeloid, Thymus, Bone Marrow

Publications for Dermatomycosis

Articles related to Dermatomycosis:

(show top 50) (show all 104)
# Title Authors Year
1
<i>In Vitro</i> Antifungal Activity of Hexahydropyrimidine Derivatives against the Causative Agents of Dermatomycosis. ( 29226215 )
2017
2
SIXTEEN YEARS OF DERMATOMYCOSIS CAUSED BY Candida spp. IN THE METROPOLITAN AREA OF PORTO ALEGRE, SOUTHERN BRAZIL. ( 27007557 )
2016
3
Dermatomycosis due to Neoscytalidium spp. ( 27296436 )
2016
4
Oral Antifungal Drugs in the Treatment of Dermatomycosis. ( 27251319 )
2016
5
Dermatomycosis caused by Paranannizziopsis australasiensis in five tuatara (Sphenodon punctatus) and a coastal bearded dragon (Pogona barbata) in a zoological collection in New Zealand. ( 27074995 )
2016
6
Dermatomycosis in three central bearded dragons (Pogona vitticeps) associated with Nannizziopsis chlamydospora. ( 26951329 )
2016
7
Dermatomycosis frequency and localization sites. ( 25870481 )
2015
8
Dermatomycosis. ( 25231229 )
2014
9
Species distribution and phospholipase activity of fungi isolated from children with dermatomycosis from child day care units in Natal, Brazil. ( 23279304 )
2013
10
Successfully treated dermatomycosis in California sea lions (Zalophus californianus). ( 23805567 )
2013
11
Dermatomycosis in lower limbs of diabetic patients followed by podiatry consultation. ( 23147514 )
2013
12
Prevalence of dermatomycosis in a Brazilian tertiary care hospital. ( 22936103 )
2012
13
Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review. ( 22233283 )
2012
14
Geotrichum candidum as etiological agent of horse dermatomycosis. ( 20970928 )
2011
15
In vitro antifungal activity of dihydroxyacetone against causative agents of dermatomycosis. ( 20936361 )
2011
16
Scopulariopsis brevicaulis as the cause of dermatomycosis. ( 20361882 )
2010
17
Dermatomycosis in a pet inland bearded dragon (Pogona vitticeps) caused by a Chrysosporium species related to Nannizziopsis vriesii. ( 19659541 )
2009
18
Dermatomycosis caused by common and rare fungi in Mumbai. ( 18797079 )
2008
19
Dermatomycosis in renal transplant recipients in Adana, Turkey. ( 18937667 )
2008
20
Dermatomycosis, hyperhydrosis, and mechanical injury to skin of the feet in Croatian soldiers during war in Croatia 1991-1992. ( 18751600 )
2008
21
Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature. ( 17007544 )
2006
22
Geomyces pannorum as a possible causative agent of dermatomycosis and onychomycosis in two patients. ( 16603097 )
2006
23
Trichophyton mentagrophytes var. quinckeanum as a cause of zoophilic dermatomycosis in a human family. ( 16642661 )
2005
24
Comparison of trypsin treatment method and standard laboratory technique for diagnosis of dermatomycosis. ( 15691144 )
2004
25
In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China. ( 15504124 )
2004
26
Four cases of dermatomycosis: superficial cutaneous infection by Alternaria or Bipolaris. ( 14604084 )
2003
27
Epidemiology of dermatomycosis in the eastern Croatia--today and yesterday. ( 12955886 )
2003
28
Continuous itraconazole treatment for onychomycosis and dermatomycosis: an overview of safety. ( 10523732 )
1999
29
Diagnosing dermatomycosis in general practice. ( 10625138 )
1999
30
Dermatomycosis in and around Aurangabad. ( 11127378 )
1999
31
Occurrence of dermatomycosis (ringworm) due to Trichophyton verrucosum in dairy calves and its spread to animal attendants. ( 10192093 )
1998
32
Dermatomycosis of the toe web caused by Curvularia lunata. ( 10030080 )
1998
33
Mycological aspects of dermatomycosis. ( 20948114 )
1996
34
Mycological aspects of dermatomycosis in Yavatmal (Maharashtra). ( 20952978 )
1995
35
Diagnosis and management of cases of suspected dermatomycosis in The Netherlands: influence of general practice based potassium hydroxide testing. ( 7612337 )
1995
36
Double-blind comparative examination of ketoconazole 1% cream and clotrimazole 2% ointment in superficial dermatomycosis. ( 8278940 )
1993
37
Response to treatment and recurrence of dermatomycosis in patients with diabetes. ( 8272485 )
1993
38
Mycological aspects of dermatomycosis in Ludhiana. ( 8300168 )
1993
39
Dermatomycosis in dogs. ( 2710156 )
1989
40
Clinical efficacy of terbinafine in 629 Japanese patients with dermatomycosis. ( 2689013 )
1989
41
Fenticonazole cream once daily in dermatomycosis, a double-blind controlled trial versus bifonazole. ( 3049173 )
1988
42
Usefulness of ketoconazole (Nizoral) in the treatment of androgenization symptoms in women suffering concurrently from candidiasis or dermatomycosis. ( 3253961 )
1988
43
Dermatomycosis in Udaipur region (Rajasthan). ( 3330981 )
1987
44
Dermatomycosis in southeast Rajasthan. ( 3878377 )
1985
45
Dermatomycosis in ranch foxes. ( 6511596 )
1984
46
Dermatomycosis in a pig and a ram. ( 6710841 )
1984
47
Patient noncompliance in dermatomycosis. Results of a survey among dermatologists and general practitioners and patients. ( 6526093 )
1984
48
The pros and cons of an oral treatment of dermatomycosis. ( 6098489 )
1984
49
Tinea versicolor dermatomycosis in the goat. ( 6735879 )
1984
50
Ketoconazole in the treatment of dermatomycosis in cats and dogs. ( 6314635 )
1983

Variations for Dermatomycosis

Expression for Dermatomycosis

Search GEO for disease gene expression data for Dermatomycosis.

Pathways for Dermatomycosis

GO Terms for Dermatomycosis

Molecular functions related to Dermatomycosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein-containing complex binding GO:0044877 8.96 DNM1 RPS3
2 kinase binding GO:0019900 8.62 CHIA RPS3

Sources for Dermatomycosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....